1. Home
  2. UEIC vs APLT Comparison

UEIC vs APLT Comparison

Compare UEIC & APLT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Universal Electronics Inc.

UEIC

Universal Electronics Inc.

HOLD

Current Price

$3.23

Market Cap

36.9M

ML Signal

HOLD

Logo Applied Therapeutics Inc.

APLT

Applied Therapeutics Inc.

HOLD

Current Price

$0.25

Market Cap

38.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
UEIC
APLT
Founded
1986
2016
Country
United States
United States
Employees
N/A
N/A
Industry
Consumer Electronics/Appliances
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Staples
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
36.9M
38.1M
IPO Year
1993
2019

Fundamental Metrics

Financial Performance
Metric
UEIC
APLT
Price
$3.23
$0.25
Analyst Decision
Buy
Buy
Analyst Count
2
5
Target Price
$9.25
$4.13
AVG Volume (30 Days)
148.9K
25.4M
Earning Date
11-06-2025
11-13-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$390,997,000.00
$1,000,000.00
Revenue This Year
$0.57
N/A
Revenue Next Year
N/A
$5,935.35
P/E Ratio
N/A
N/A
Revenue Growth
2.35
N/A
52 Week Low
$2.69
$0.22
52 Week High
$12.50
$2.44

Technical Indicators

Market Signals
Indicator
UEIC
APLT
Relative Strength Index (RSI) 43.13 28.15
Support Level $3.06 $0.24
Resistance Level $3.36 $0.27
Average True Range (ATR) 0.19 0.08
MACD 0.08 -0.02
Stochastic Oscillator 75.70 4.00

Price Performance

Historical Comparison
UEIC
APLT

About UEIC Universal Electronics Inc.

Universal Electronics Inc is a United States-based company that principally designs, develops, manufactures, ships, and supports control and sensor technology solutions and a broad line of universal control systems, audio-video (AV) accessories, wireless security, and smart home products that are used by the world's brands in the video services, consumer electronics, security, home automation, climate control and home appliance markets. It generates its total revenue from the United States.

About APLT Applied Therapeutics Inc.

Applied Therapeutics Inc is a clinical-stage biopharmaceutical company, developing a pipeline of novel product candidates against validated molecular targets in indications of high unmet medical need. The company's drug compounds pipeline includes AT-007 which is a novel central nervous system, penetrant ARI that it is developing for the treatment of rare metabolic diseases, including Galactosemia and Sorbitol Dehydrogenase (SORD) Deficiency, AT-001 for the treatment of diabetic cardiomyopathy, and AT-003 for the treatment of diabetic retinopathy.

Share on Social Networks: